mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.4 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.4 |